摘要
2011年5月至2012年5月,对内蒙古第四医院收治的13例利福平耐药结核病患者采用标准方案进行治疗,观察治疗后每个月的细菌学、影像学变化,并观察停药后3、6、12、18、24个月的细菌学、影像学变化.13例患者中9例治愈,3例完成疗程,1例失败;12例完成24个月随访.采用标准方案治疗的13例利福平耐药结核病患者,疗效理想,耐受性好,复发率低,值得进一步积累病例进行临床观察,评价该方案的有效性.
Standardized treatment is applied to 13 rifampicin-resistant TB patients in The Fourth Hospital of Inner Mongolia from May, 2011 to May, 2012. The bacteriology and imaging changes were observed each month during the treatment period and at 3, 6, 12, 18, 24 months after treatment. Of the 13 patients, 9 had been cured, 3 had completed treatment, and 1 had failed. Twelve patients have completed 24 months follow-up. The treatment of 13 rifampicin-resistant TB patients with standardized regimen was ideal with good tolerance and low recurrence rate. It is worth to collect more cases for clinical observation to evaluate the effectiveness of the regimen.
出处
《结核病与肺部健康杂志》
2017年第1期82-84,共3页
Journal of Tuberculosis and Lung Health
基金
中华人民共和国卫生部与比尔及梅琳达·盖茨基金会合作项目(2011CDCC)
关键词
结核
利福平
结核
抗多种药物性
方案评价
治疗结果
Tuberculosis
Rifampin
Tuberculosis, multidrug-resistant
Program evaluation
Treatment outcome
